What's breaking now, across thousands of outlets.
(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) announced on Wednesday that it has agreed to sell a Rare Pediatric Disease Priority Review Voucher for $203 million.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
A Milimani Anti-Corruption High Court has cancelled bond terms granted to former Kiambu Governor Ferdinand Waititu and his co-convict Luka Mwangi Wahinya in a Ksh588,749,000 graft case.
Shares of conglomerate that owns AOL and Vimeo jump more than 50% on news of expanded investment by Nebraska asset manager
This reliable dividend ETF could offer strong yields and meaningful protection in case of a tech stock crash.
Gulf stock markets closed mixed on Wednesday, with Saudi shares leading losses after an attack on Saudi Aramco headquarters deepened fears of an escalating conflict between the kingdom and Yemen’s…
Odds for an Oct. 28 quarter-point hike increased to 53.7% from just 22.1% a day ago.
Standard Chartered’s Saabir Salad analyzes Hungary’s fiscal outlook and its implications for Euro adoption and the Forint.
